NM_016239.4:c.5380C>T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_016239.4(MYO15A):c.5380C>T(p.Arg1794Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1794H) has been classified as Uncertain significance.
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 249512 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461802Hom.: 0 Cov.: 38 AF XY: 0.0000138 AC XY: 10AN XY: 727198 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Arg1794Cys variant in MYO15A has not been previously reported in individuals with hearing loss, but has been identified in 0.01% (1/8406) of European Americ an chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.e du/EVS/). Although this variant has been seen in the general population, its fre quency is not high enough to rule out a pathogenic role. Computational predictio n tools and conservation analyses suggest that the Arg1794Cys variant may impact the protein, though this information is not predictive enough to determine path ogenicity. In summary, the clinical significance of the Arg1794Cys variant is un certain. -
Inborn genetic diseases Uncertain:1
The c.5380C>T (p.R1794C) alteration is located in exon 21 (coding exon 20) of the MYO15A gene. This alteration results from a C to T substitution at nucleotide position 5380, causing the arginine (R) at amino acid position 1794 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at